Impact of MRI in the management and staging of cancer of the uterine cervix

Figures & data

Figure 1. Patient with cervical carcinoma diagnosed as IIa according to FIGO T2-weighted MR-images sagittal (a) and transaxial (b,c) shows a 3 cm tumour with (a,b) lobulated parametrial extensions (arrows) as well as (c) pelvic nodal metastases (arrows).

Figure 2. The studied patient group divided by treatment and outcome.

Table I. Distribution of stage in each treatment group.

FIGO stage	Surgery n	%	Radiochemo n	%
Ia	9	7.2	0	0
Ib1	77	61.6	3	5.2
Ib2	23	18.4	3	5.2
Iia	13	10.4	2	3.4
Iib	2	1.6	31	53.4
IIIa	1	0.8	1	1.7
IIIb	0	0	17	29.4
IV	0	0	1	1.7

Table II. Distribution of histopathological types in each treatment group.

Histopathology	Surgery n	%	Radiochemo n	%
Squamous	78	62.4	36	62.1
Adenocarcinoma	29	23.2	11	19
Adenosquamous	11	8.8	1	1.7
Clear cell	1	0.8	1	1.7
Glassy cell	5	4	8	13.8
Other	1	0.8	1	1.7

short-legendPicture 1.